Schedule 7

SEVENTH SCHEDULERegulations 2(1) and 13D(3)First column Second column Third columnType of CTGTP treatment Operative date for treatment received Maximum amount that may be withdrawn1.Administration of Kymriah for B‑cell acute lymphoblastic leukaemia With effect from 1 October 2025 $4,680 per course of treatment per patient2.Administration of Kymriah for diffuse large B‑cell lymphoma With effect from 1 October 2025 $4,680 per course of treatment per patient3.Administration of Yescarta for diffuse large B‑cell lymphoma or high‑grade B‑cell lymphoma With effect from 1 October 2025 $4,680 per course of treatment per patient